These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Phosphodiesterases as targets for intermittent claudication. Liu Y; Shakur Y; Kambayashi J Handb Exp Pharmacol; 2011; (204):211-36. PubMed ID: 21695642 [TBL] [Abstract][Full Text] [Related]
51. Evidence-based symptom relief of intermittent claudication: efficacy and safety of cilostazol. Donnelly R Diabetes Obes Metab; 2002 Mar; 4 Suppl 2():S20-5. PubMed ID: 12180354 [TBL] [Abstract][Full Text] [Related]
52. Cilostazol approved for use in intermittent claudication. Miller JL Am J Health Syst Pharm; 1999 Mar; 56(5):404. PubMed ID: 10096695 [No Abstract] [Full Text] [Related]
53. Management of peripheral arterial disease in the elderly: focus on cilostazol. Falconer TM; Eikelboom JW; Hankey GJ; Norman PE Clin Interv Aging; 2008; 3(1):17-23. PubMed ID: 18488875 [TBL] [Abstract][Full Text] [Related]
54. Pentoxifylline for intermittent claudication. Salhiyyah K; Senanayake E; Abdel-Hadi M; Booth A; Michaels JA Cochrane Database Syst Rev; 2012 Jan; 1():CD005262. PubMed ID: 22258961 [TBL] [Abstract][Full Text] [Related]
55. Lack of relationship between gait parameters and physical function in peripheral arterial disease. Scherer SA; Hiatt WR; Regensteiner JG J Vasc Surg; 2006 Oct; 44(4):782-8. PubMed ID: 17012002 [TBL] [Abstract][Full Text] [Related]
56. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials. Hood SC; Moher D; Barber GG CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633 [TBL] [Abstract][Full Text] [Related]
57. Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study. Strandness DE; Dalman RL; Panian S; Rendell MS; Comp PC; Zhang P; Forbes WP Vasc Endovascular Surg; 2002; 36(2):83-91. PubMed ID: 11951094 [TBL] [Abstract][Full Text] [Related]
58. Cilostazol: a replacement for pentoxifylline? Shukla V Issues Emerg Health Technol; 1999 Jul; (7):1-4. PubMed ID: 11811214 [No Abstract] [Full Text] [Related]
59. The vascular and biochemical effects of cilostazol in diabetic patients with peripheral arterial disease. O'Donnell ME; Badger SA; Sharif MA; Makar RR; Young IS; Lee B; Soong CV Vasc Endovascular Surg; 2009; 43(2):132-43. PubMed ID: 19131370 [TBL] [Abstract][Full Text] [Related]
60. [Randomized study of tolerability, safety and efficacy of Pletax in intermittent claudication]. Kazantsev AN; Goriunov SV; Ershova OB; Erofeeva SB; Gurgenian EV Angiol Sosud Khir; 2021; 27(1):7-16. PubMed ID: 33825723 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]